All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

tetrofosmin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
insecticides, anthelminthics, pesticides etc., phosphorous derivatives	3592	127502-06-1

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: tetrofosmin	Tetrofosmin is a diagnostic agent used to assess areas of reversible myocardial ischemia in the presence or absence of infracted myocardium and is also used to assess ventricular function. Molecular weight: 382.46 Formula: C18H40O4P2 CLOGP: -0.69 LIPINSKI: 0 HAC: 4 HDO: 0 TPSA: 36.92 ALOGS: -5.76 ROTB: 19 Status: OFP Legend: OFP - off patent OFM - off market ONP - on patent

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
No adverse event	286.67	81.48	56	162	41349	63447455
Radioisotope scan abnormal	277.47	81.48	29	189	204	63488600

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Radioisotope scan abnormal	381.18	81.83	41	178	203	34956509
No adverse event	349.82	81.83	66	153	22861	34933851

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
No adverse event	359.25	59.55	69	265	37123	79706931
Radioisotope scan abnormal	305.20	59.55	35	299	495	79743559
Drug ineffective	60.66	59.55	43	291	1080870	78663184

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
D06094	KEGG_DRUG
C1366036	UMLSCUI
CHEMBL1615784	ChEMBL_ID
DB11180	DRUGBANK_ID
4274	PUBCHEM_CID
6886	INN_ID
3J0KPB596Q	UNII
1311569	RXNORM
23732	MMSL
d06761	MMSL
009786	NDDF

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Myoview	HUMAN PRESCRIPTION DRUG LABEL	1	17156-024	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	0.23 mg	INTRAVENOUS	NDA	26 sections
Myoview	HUMAN PRESCRIPTION DRUG LABEL	1	17156-024	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	0.23 mg	INTRAVENOUS	NDA	26 sections
Myoview	HUMAN PRESCRIPTION DRUG LABEL	1	17156-026	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	1.38 mg	INTRAVENOUS	NDA	24 sections
Myoview	HUMAN PRESCRIPTION DRUG LABEL	1	17156-026	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	1.38 mg	INTRAVENOUS	NDA	24 sections
Myoview	HUMAN PRESCRIPTION DRUG LABEL	1	17156-026	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	1.38 mg	INTRAVENOUS	NDA	24 sections
Tetrofosmin	HUMAN PRESCRIPTION DRUG LABEL	1	51808-223	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	0.35 mg	INTRAVENOUS	Unapproved drug other	7 sections
Tetrofosmin	HUMAN PRESCRIPTION DRUG LABEL	1	51808-223	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	0.35 mg	INTRAVENOUS	Unapproved drug other	7 sections